Japan CBD Regulatory Report 2020: No Distinction Between Cannabis and Hemp – ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)--The "Regulatory CBD Report: No Distinction Between Cannabis and Hemp in Japan" report has…
6 years ago
GungHo Online Entertainment Hosts TEPPEN WORLD CHAMPIONSHIP 2020 Finals
32 finalists compete for a chance to win from a 5M Yen prize pool TOKYO--(BUSINESS…
6 years ago
ASC20-21 Student Supercomputer Challenge: Search for Pulsars and Inspire the Universe Exploration
BEIJING, China--(BUSINESS WIRE)--The preliminary round of the 2020-2021 ASC Student Supercomputer Challenge (ASC20-21) has kicked…
6 years ago
Dialpad Raises Additional $10M from SoftBank Corp. to Accelerate Product Expansion in Japan and APAC
Dialpad expands footprint in APAC, empowering global workforces with Voice Intelligence through its AI-powered cloud…
6 years ago
Blue Yonder Named a Great Place to Work®
Company now recognized as a Great Place to Work Certified™ in the U.S. and India…
6 years ago
Arista Unveils Attack Surface Assessment Service
Delivers AI-driven advanced threat hunting and incident response expertise SANTA CLARA, Calif.--(BUSINESS WIRE)--Arista Networks (NYSE:ANET)…
6 years ago
DHL Delivers First Batch of COVID-19 Vaccines to Singapore
Rigorous planning and testing to ensure supply chain supports vaccine's stringent temperature requirements SINGAPORE -…
6 years ago
HitGen Announces License Agreement With Merck & Co., Inc., Kenilworth, NJ USA to Access Compounds for Potential Development of a Novel Class of Drugs
CHENGDU, China--(BUSINESS WIRE)--HitGen Inc. is pleased to announce that HitGen and Merck & Co., Inc.,…
6 years ago
Propanc Biopharma Receives First Granted Patent for Method to Treat Cancer Stem Cells from Australian Patent Office
MELBOURNE, Australia--(BUSINESS WIRE)--Propanc Biopharma, Inc. (OTC: PPCB) (“Propanc” or the “Company”), a biopharmaceutical company developing…
6 years ago
First Patients, Including a COVID-19 Patient, Treated with Abiomed’s Innovative ECMO Technology
DANVERS, Mass.--(BUSINESS WIRE)--Abiomed (NASDAQ: ABMD) announces the first two patients in the world have been…
6 years ago